Doctors check for breast cancer through a combination of imaging, physical examination, and, when needed, tissue sampling. The process typically starts with screening mammograms for people without symptoms, or diagnostic imaging for those who notice a change. Most findings turn out to be benign, but understanding each step can help you know what to expect and why your doctor may order additional tests.
Mammograms: The Primary Screening Tool
A mammogram is a low-dose X-ray of the breast and remains the most reliable first-line tool for catching cancer early, often years before a lump can be felt. During the exam, each breast is compressed between two plates while images are taken from different angles. The compression is brief and can be uncomfortable, but it spreads the tissue so the radiologist can see through it clearly.
Most facilities now offer 3D mammography (also called tomosynthesis), which takes multiple thin-slice images and reconstructs them into a three-dimensional picture. Compared to traditional 2D mammograms, 3D imaging detects roughly 24% more cancers per screening round. It also reduces false alarms, because the radiologist can scroll through layers of tissue instead of trying to read one flat image where structures overlap.
The American Cancer Society recommends that women at average risk have the option to start annual mammograms at 40. From 45 to 54, yearly screening is recommended. At 55 and older, you can switch to every other year or continue annually. Screening should keep going as long as you’re in good health and expected to live at least 10 more years.
What Your Density Report Means
After every mammogram, you’ll receive a report that includes a breast density category. Under an FDA rule, mammography facilities are now required to notify you in plain language about your density. The four categories range from “almost entirely fatty” to “extremely dense.” If your tissue falls into one of the two dense categories, the notification will explain that dense tissue makes cancers harder to spot on a mammogram and slightly raises your overall risk. It may also note that additional imaging tests could help.
About half of women who get mammograms have dense breasts. If you’re one of them, your doctor may recommend a supplemental screening ultrasound or breast MRI, depending on your overall risk profile. Dense tissue appears white on a mammogram, and so do tumors, which is why cancers can hide in dense breasts more easily.
The Clinical Breast Exam
A clinical breast exam is a hands-on evaluation your doctor or nurse practitioner performs during a checkup. It has three parts: visual inspection, palpation (feeling the tissue), and a check of the lymph nodes near the breast and underarm.
During inspection, the provider looks for skin changes like dimpling, redness, or nipple pulling. During palpation, they press through the tissue systematically, checking for lumps or thickening. If a mass is found, certain features help distinguish harmless lumps from suspicious ones. Benign lumps tend to feel smooth, rubbery, and movable, and they’re often tender to the touch. Cancerous lumps are more likely to feel hard, have irregular borders, and be fixed in place rather than sliding under the fingers. A mass that changes with your menstrual cycle is almost always benign.
The exam is most accurate when done at a point in your cycle that’s not right before your period, when normal hormonal swelling can make the tissue lumpy and harder to read.
Ultrasound and Additional Imaging
If a mammogram flags something suspicious, or if you or your doctor feel a new lump, the next step is usually a diagnostic mammogram combined with an ultrasound. A diagnostic mammogram takes extra, targeted views of the area in question. The ultrasound uses sound waves to produce a real-time image that can distinguish a fluid-filled cyst (almost always harmless) from a solid mass that needs further evaluation.
Ultrasound is painless. A technologist applies gel to the skin and glides a small probe over the breast. The entire process typically takes 15 to 30 minutes. For people with dense breasts and elevated risk, ultrasound sometimes serves as a supplemental screening tool alongside the annual mammogram.
Breast MRI for High-Risk Screening
Breast MRI is reserved for people whose lifetime risk of breast cancer is estimated at 20% or higher. That group includes carriers of BRCA1 or BRCA2 gene mutations, who face a lifetime risk of roughly 69% to 72%, as well as people who received chest radiation at a young age. The American Cancer Society recommends that high-risk individuals get both a mammogram and a breast MRI every year, typically starting at age 30.
An MRI uses magnets and radio waves instead of radiation. You lie face down on a padded table, and contrast dye is injected into a vein so that abnormal tissue lights up on the images. The scan takes about 30 to 45 minutes. MRI is extremely sensitive, which is why it’s valuable for high-risk screening, but it also produces more false positives than mammography, so it’s not used as a routine tool for everyone.
Genetic Risk Assessment
Your doctor may recommend genetic counseling if your personal or family history raises red flags for an inherited mutation. The U.S. Preventive Services Task Force identifies several factors that warrant a formal risk assessment: breast cancer diagnosed before age 50, cancer in both breasts, a combination of breast and ovarian cancer in one person, male relatives with breast cancer, multiple cases of breast cancer across the family, or Ashkenazi Jewish ancestry.
If a brief screening tool suggests elevated risk, genetic counseling comes first. A counselor reviews your history in detail and helps you decide whether a blood test for BRCA1, BRCA2, or other mutations makes sense. Testing is only recommended when the results would actually change your screening or prevention plan. A positive result, for instance, would move you into the high-risk category and qualify you for annual MRI starting as early as age 25.
Biopsy: Confirming a Diagnosis
Imaging can identify suspicious areas, but only a biopsy can confirm whether cancer is present. During a biopsy, a small sample of tissue is removed and examined under a microscope. There are two main types used for breast concerns.
A fine-needle aspiration uses a very thin needle to withdraw cells or fluid. It’s quick and causes minimal discomfort, but it collects a small sample, so it’s most useful for cysts or when a rapid initial answer is needed. A core-needle biopsy uses a slightly larger needle, sometimes with a vacuum-assisted device, to extract a piece of tissue about the size of a grain of rice. This provides more material for the pathologist and is the standard approach for solid masses.
Both procedures are typically done in an outpatient setting with local numbing. Imaging guidance (ultrasound or mammography) helps the doctor place the needle precisely. You can usually return to normal activities within a day or two, though mild bruising and soreness at the site are common. Results generally come back within a few business days.
Understanding Your Results
Breast imaging results are reported using a standardized scoring system called BI-RADS, with categories numbered 0 through 6. Knowing these numbers can help you understand what happens next.
- Category 0: The images were incomplete or unclear, and additional scans are needed before a final assessment.
- Category 1: Negative. No cancer was found.
- Category 2: Benign finding. Something showed up, but it’s clearly not cancer.
- Category 3: Probably benign. A short-interval follow-up (usually in six months) is recommended to confirm it isn’t changing.
- Category 4: Suspicious. A biopsy is recommended. This category spans a wide range, from findings with a low chance of being cancer (category 4A) to those with a 50% to 95% likelihood (category 4C).
- Category 5: Highly suggestive of cancer, with about a 95% chance the finding is malignant. A biopsy is strongly recommended.
- Category 6: Used only for people who already have a confirmed cancer diagnosis, to track how the tumor responds to treatment.
Getting a category 0 or even a category 4 does not mean you have cancer. Most biopsies prompted by category 4 findings come back benign. The system is designed to cast a wide net so that true cancers aren’t missed.
Breast Cancer Screening in Men
Men account for a small percentage of breast cancer cases, and there’s no routine screening program for them. Diagnosis typically begins when a man notices a symptom: a lump or swelling in the breast, skin redness or flaking, nipple discharge, or a nipple that pulls inward. The diagnostic steps mirror those for women. A doctor performs a clinical exam, orders imaging (usually a mammogram and ultrasound of the affected area), and follows up with a biopsy if the findings look suspicious. Because breast cancer in men is uncommon, many cases are caught later than in women, making prompt evaluation of any breast changes important.